Source: International Congress 2016 – Clinical and molecular studies in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Agnieszka Cybulska (Kraków, Poland), Agnieszka Cybulska, Stanislawa Bazan-Socha, Lucyna Mastalerz, Lech Zareba, Romy Kremers, Michal Zabczyk, Grazyna Pulka, Teresa Iwaniec, Anetta Undas. Prothrombotic alterations to blood coagulation and fibrinolysis in clinically stable asthma. Eur Respir J 2016; 48: Suppl. 60, 1978

Member's Comments

No comment yet.

Related content which might interest you: The temporal stability of coagulation and fibrinolytic factors in patients with asthma and healthy subjects Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 Coagulation activity increases with disease severity in patients with asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 PP220 – Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: ERS Lung Science Conference 2021 Year: 2021 Hypercoagulability in patients with stable COPD assessed by coagulation factor levels Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 Diesel exhaust-induced effects on markers of systemic inflammation and blood coagulation in patients with COPD Source: Annual Congress 2004 - Particle effects on humans Year: 2004 24-hour blood pressure monitoring and clinical differentiations in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Endothelial dysfunction and arterial rigidity in patients with bronchial asthma out of an exacerbation Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Blood inflammatory phenotypes of asthma in the Constances cohort Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial Source: Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017 Year: 2017 24-hour blood pressure monitoring and 10 years systemic coronary risk evaluation in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Evaluation of fractional exhaled nitric oxide and peripheral blood eosinophil count as biomarkers in patients with refractory asthma Source: Annual Congress 2013 –Asthma Year: 2013 Coagulation factors in the airways in moderate and severe asthma Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 Platelet indices as inflammatory markers in stable COPD Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis Year: 2007 Eosinophilic inflammation amplifies the prednisolone-induced prothrombotic state in asthma Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Crucial role of thrombin-activated fibrinolysis inhibitor in the pathogenesis of chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation Source: Eur Respir J 2007; 30: 423-428 Year: 2007